Story available to Subscribers Only

Thank you for your interest in CTFN content. To read this story, please request a free trial Request Free Trial CTFN is your source for in-depth news coverage on mergers, events, and major corporate actions, reported with the detail and accuracy commensurate with a professional investor’s perspective.
To learn more about our team’s reporting, please view the Insights section, or contact featured

360b /

Competition Commission of India Has Asked Bayer for Remedies

The Competition Commission of India has asked Bayer for remedies in connection with the company’s planned takeover of Monsanto, sources told CTFN.featured

Monsanto-Bayer Regulatory Clearance in India Expected April or May

The Competition Commission of India is likely to clear the Monsanto-Bayer deal by the end of April or mid-May,featured

Monsanto/Bayer Review Likely to Go to Phase Two in India

The Competition Commission of India is likely to move the Monsanto/Bayer deal into Phase Two, sources following the situation believe. Anshuman Sakle, a competition partner at Cyril Amarchand Mangaldas, explained thatfeatured

Monsanto and Bayer in Remedy Discussions with Indian Regulator

Monsanto and Bayer are in pre-phase 2 remedy negotiations with the Competition Commission of India, several antitrust sources familiarfeatured

Indian Regulatory Process for Monsanto/Bayer Likely Follows EU

With additional reporting by Valeria Camerino – A number of sources told CTFN that India’s antitrust regulator only recently received a revised application from Bayer and Monsanto, and is likelyfeatured

360b /

Bayer to Refile Monsanto Deal in India

The Monsanto/Bayer transaction will be refiled with the Competition Commission of India, a source close to the deal said. “The paperwork was done within the first thirty days asfeatured

360b /

Interested in a trial?

Simply fill out the form below and one of our representatives will be in touch.